Lexaria Bioscience (LEXX) Amortizatization of Intangibles (2015 - 2026)
Lexaria Bioscience's (LEXX) quarterly Amortizatization of Intangibles came in at $1802.0 in Q1 2026, down 22.56% year-on-year from $2327.0 in Q1 2025, and down 6.97% quarter-over-quarter from $1937.0 in Q4 2025.
Lexaria Bioscience (LEXX) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Lexaria Bioscience has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $1802.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $1802.0, down 22.56% year-over-year; the trailing twelve-month figure through Feb 2026 was $8008.0 (down 6.99% YoY), and the FY2025 annual result was $9047.0, up 35.6% from the prior year.
- Amortizatization of Intangibles came in at $1802.0 for Q1 2026 at Lexaria Bioscience, down from $1937.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2773.0 in Q1 2024 to a low of $67.0 in Q4 2023.
- The 4-year median for Amortizatization of Intangibles is $2134.5 (2025), against an average of $1945.8.
- Across the five-year window, Amortizatization of Intangibles surged 3558.21% in 2024 and dropped 22.56% in 2026, its largest moves.
- Lexaria Bioscience's Amortizatization of Intangibles stood at $67.0 in 2023, then soared by 3558.21% to $2451.0 in 2024, then retreated by 20.97% to $1937.0 in 2025, then declined by 6.97% to $1802.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $1802.0 (Q1 2026), $1937.0 (Q4 2025), and $2070.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Lexaria Bioscience | 7.49 Mn | 1.97 Mn | 20,000.00 | 1,802.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1,802.00 |
| Feb 28, 2026 | 1,802.00 |
| Nov 30, 2025 | 1,937.00 |
| Nov 30, 2025 | 1,937.00 |
| Aug 31, 2025 | 2,070.00 |
| Aug 31, 2025 | 2,070.00 |
| May 31, 2025 | 2,199.00 |
| May 31, 2025 | 2,199.00 |
| Feb 28, 2025 | 2,327.00 |
| Feb 28, 2025 | 2,327.00 |
| Nov 30, 2024 | 2,451.00 |
| Nov 30, 2024 | 2,451.00 |
| Aug 31, 2024 | 1,171.00 |
| Aug 31, 2024 | 1,171.00 |
| May 31, 2024 | 2,661.00 |
| May 31, 2024 | 2,661.00 |
| Feb 29, 2024 | 2,773.00 |
| Feb 29, 2024 | 2,773.00 |
| Nov 30, 2023 | 67.00 |
| Nov 30, 2023 | 67.00 |